Efficacy and safety of a Chinese herbal formula Maxing Ganshi Decoction in children with community-acquired pneumonia: A randomized, double-blind, placebo-controlled, multicenter trial
Background: As one of the most commonly used Chinese medicine formula in the manage of respiratory diseases, Maxing Ganshi Decoction (MGD) has been demonstrated to improve the clinical symptoms of pneumonia. To evaluate the efficacy and safety of MGD in treating children with community-acquired pneu...
Main Authors: | Yujiao Zheng, Changren Shi, Yaowei Han, Xinmin Li, Lijing Dong, Yan Li, Hui Chen, Yushui Wang, Jinsong Li, Geli Liu, Rong Ma, Fengmei Lian, Xiaolin Tong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.948831/full |
Similar Items
-
Assessing the efficacy and safety of Yinqiao powder-maxing Ganshi decoction in the treatment of the major symptoms of mild and moderate COVID-19 by telemedicine–study protocol for a randomized, double-blind, placebo-controlled trial
by: Chi Him Sum, et al.
Published: (2024-01-01) -
The rational dose for MaXingShiGan decoction is crucial for its clinical effectiveness in treating bronchial pneumonia: three randomized, double-blind, dose-parallel controlled clinical studies
by: Xuedong An, et al.
Published: (2023-11-01) -
Sanhua decoction: Current understanding of a traditional herbal recipe for stroke
by: Lanlan Zheng, et al.
Published: (2023-04-01) -
Wuhu decoction combined with azithromycin for treatment of Mycoplasma pneumoniae pneumonia in Asian children: a systematic review and meta analysis of randomized controlled trials
by: Shuo Yang, et al.
Published: (2024-04-01) -
Clinical and Basic Research on Renshen Yangrong Decoction
by: Wei Sheng, et al.
Published: (2019-12-01)